C1QTNF9 and diabetic cardiomyopathy: Because different anti-inflammatory maneuvers improved the experimental diabetic cardiomyopathy in mice and rats, the anti-inflammatory effects of CTRP9, which had been previously observed in vitro and were also described for the related adiponectin, likely contribute to the protective action of CTRP9 in diabetic cardiomyopathy [46,47,48,49,50,51,52].